EUCTR2007-002681-34-GB进行中（未招募）1 期
Dual antiplatelet therapy in the acute phase following stroke and TIA; which is the best regimen?
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Patients with greater than or equal to 50% carotid artery stenosis AND symptoms of transient ischaemic attack or stroke within the last month.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. antiplatelet/antithrombotic medication other than aspirin (although low does prophylactic subcutaneous heparin for DVT prophylaxis will be allowed)
- •2. patients with prosthetic heart valves who have gaseous embolic signals.
- •3. patients in who clopidogrel or dipyridamole are contraindicated.
- •4. If carotid endarterectomy is planned during the study.
研究者
相似试验
已完成
不适用
What is the best treatment after stroke?ISRCTN68019845St George's Heathcare NHS Trust (UK)60
已完成
不适用
oborI dual antiplatelet therapy as aPPropriate duratiON (NIPPON)Coronary Artery DiseaseJPRN-UMIN000006698PO Associations for Establishment of Evidence in Interventions4,598
进行中（未招募）
不适用
ACUTE-PRASJPRN-jRCTs031220079Fujimoto Shigeru200
进行中（未招募）
1 期
Single versus Dual Antiplatelet Therapy in patients with Incomplete Revascularization after Coronary artery bypass graft surgeryEUCTR2017-001754-33-ITIVERSITÀ CAMPUS BIO-MEDICO DI ROMA800
已完成
4 期
Duration of Dual Anti-Platelet Therapy (DUAL-ACS)Acute Coronary SyndromeCoronary Artery DiseaseNCT03252249University of Edinburgh5,094